Allspring Global Investments Holdings LLC Has $531,000 Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Allspring Global Investments Holdings LLC decreased its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHCFree Report) by 33.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 45,820 shares of the company’s stock after selling 22,721 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Phibro Animal Health were worth $531,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of PAHC. China Universal Asset Management Co. Ltd. increased its stake in shares of Phibro Animal Health by 358.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock worth $27,000 after purchasing an additional 1,843 shares during the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Phibro Animal Health by 19.2% during the 4th quarter. Nisa Investment Advisors LLC now owns 8,500 shares of the company’s stock worth $98,000 after purchasing an additional 1,370 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of Phibro Animal Health during the 3rd quarter worth $126,000. Illinois Municipal Retirement Fund acquired a new position in shares of Phibro Animal Health during the 3rd quarter worth $162,000. Finally, Jump Financial LLC acquired a new position in shares of Phibro Animal Health during the 3rd quarter worth $198,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Stock Performance

NASDAQ:PAHC opened at $12.44 on Friday. Phibro Animal Health Co. has a 1 year low of $9.40 and a 1 year high of $15.96. The firm’s fifty day simple moving average is $12.82 and its 200 day simple moving average is $11.77. The company has a current ratio of 3.12, a quick ratio of 1.60 and a debt-to-equity ratio of 1.66. The firm has a market capitalization of $503.82 million, a PE ratio of 34.56, a PEG ratio of 5.02 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last posted its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. The business had revenue of $249.90 million for the quarter, compared to analyst estimates of $242.91 million. On average, sell-side analysts anticipate that Phibro Animal Health Co. will post 1.12 EPS for the current year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Wednesday, March 6th were paid a $0.12 dividend. The ex-dividend date was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 3.86%. Phibro Animal Health’s payout ratio is presently 133.33%.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Tuesday, April 9th.

Get Our Latest Research Report on Phibro Animal Health

About Phibro Animal Health

(Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

See Also

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Co. (NASDAQ:PAHCFree Report).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.